Sh Fosun Pharma | 600196

Stock Price
30.19
Daily Change
0.86 2.93%
Monthly
13.37%
Yearly
34.12%
Q3 Forecast
29.92

Peers Price Chg Day Year Date
Cspc Pharmaceutical 11.19 0.36 3.32% 140.13% Sep/05
Sino Biopharmaceutical 8.91 0.52 6.20% 183.76% Sep/05
Jiangsu Hengrui 72.47 3.82 5.56% 63.22% Sep/05
Zhangzhou Pientzehuang Pharmaceutical 203.87 0.94 0.46% 0.69% Sep/05
Kangmei Pharma 2.03 0 0% 15.34% Sep/05
Sh Pharmaceutical 18.33 0.07 0.38% -4.78% Sep/05
WuXi AppTec 107.40 5.46 5.36% 176.80% Sep/05

Indexes Price Day Year Date
SHANGHAI 3813 46.64 1.24% 37.84% Sep/05

Sh Fosun Pharma traded at 30.19 this Friday September 5th, increasing 0.86 or 2.93 percent since the previous trading session. Looking back, over the last four weeks, Sh Fosun Pharma gained 13.37 percent. Over the last 12 months, its price rose by 34.12 percent. Looking ahead, we forecast Sh Fosun Pharma to be priced at 29.92 by the end of this quarter and at 29.13 in one year, according to Trading Economics global macro models projections and analysts expectations.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system, anti-tumor and anti-infection diseases. The Company is also engaged in medical equipment and medical diagnosis business, as well as the provision of medical services. It distributes its products primarily in domestic and overseas markets.